Q-Line Biotech IPO Details
| IPO Open Date | 2026 |
| IPO Close Date | 2026 |
| Face Value | ā¹10 Per Equity Share |
| IPO Price Band | ā¹[.] to ā¹[.] Per Share |
| Issue Size | Approx ā¹[.] Crores, 70,53,200 Equity Shares |
| Fresh Issue | Approx ā¹[.] Crores, 70,53,200 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Q-Line Biotech IPO Review & Key Points
- Review:
Q-Line Biotech IPO Market Lot
The Q-Line Biotech IPO minimum market lot is [.] shares with ā¹[.] application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | – | – | ā¹- |
| Retail Maximum | – | – | ā¹- |
| S-HNI Minimum | – | – | ā¹- |
| S-HNI Maximum | – | – | ā¹- |
| B-HNI Minimum | – | – | ā¹- |
IPO Reservation
| Investor Category | Share Offered | Shares (%) |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 50% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 35% |
Q-Line Biotech IPO Anchor Investors
| Anchor Bidding Date | 2026 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | 2026 |
| lock-in period end date 50% shares (90 Days) | 2026 |
Q-Line Biotech IPO Dates
The Q-Line Biotech IPO date is 2026 and the close date is 2026. The Q-Line Biotech IPO allotment will be finalized on 2026 and the IPO listing on 2026.
| IPO Open Date: | 2026 |
| IPO Close Date: | 2026 |
| Basis of Allotment: | 2026 |
| Refunds: | 2026 |
| Credit to Demat Account: | 2026 |
| IPO Listing Date: | 2026 |
| IPO Bidding Cut-off Time: | 2026 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Saurabh Garg, Amita Garg, Ayush Garg, Ajay Kumar Mahanty and Abhay Agrawal.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,62,74,999 | -% |
| Promoter Holding Post Issue | – | -% |
Objects of the Issue & Utilisation of Proceeds
| Purpose | Crores |
| To meet Working Capital requirements | ā¹110.00 |
| Repayment of certain borrowing availed by the Company, in part or full | ā¹90.00 |
| General Corporate Purpose | ā¹- |
About Q-Line Biotech IPO
To be updated soon
Q-Line Biotech IPO Company Financial Report
Amount ā¹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ā¹184.81 | ā¹154.97 | ā¹32.10 | ā¹251.58 |
| 2024 | ā¹206.45 | ā¹175.85 | ā¹34.44 | ā¹339.25 |
| 2025 | ā¹322.58 | ā¹261.43 | ā¹28.13 | ā¹455.49 |
Q-Line Biotech IPO Valuation – FY2025
Check Q-Line Biotech IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 17.66% |
| ROCE: | 23.74% |
| EBITDA Margin: | 22.73% |
| PAT Margin: | 8.97% |
| Debt to equity ratio: | 0.87 |
| Earning Per Share (EPS): | ā¹28.63 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 23.74% |
| Net Asset Value (NAV): | ā¹120.60 |
Peer Group Comparison
There are no listed companies in India.
IPO Lead Managers aka Merchant Bankers
- Hem Securities Ltd.
- Share India Capital Services Pvt. Ltd.
Company Address
Q-Line Biotech Ltd.
298-281,
Transport Nagar,
Kanpur Road Adjacent Transport Nagar Metro Station
Lucknow, Uttar Pradesh, 226012
Phone: +91 522-2435570
Email: compliance@qlinebiotech.com
Website: https://qlinebiotech.com/
IPO Registrar
Purva Sharegistry (India) Pvt.Limited.
Phone: +91-022-23018261/ 23016761
Email: support@purvashare.com
Website: https://www.purvashare.com/investor-service/ipo-query
Q-Line Biotech IPO FAQs
What is Q-Line Biotech IPO?
When Q-Line Biotech IPO will open for subscription?
What is Q-Line Biotech IPO Investors Portion?
How to Apply the Q-Line Biotech IPO?
What is Q-Line Biotech IPO Issue Size?
What is Q-Line Biotech IPO Price Band?
What is Q-Line Biotech IPO Lot Size?
What is the Q-Line Biotech IPO Allotment Date?
What is the Q-Line Biotech IPO Listing Date?
Note: The Q-Line Biotech IPO price band and date are officially announced. The (Q-Line Biotech IPO grey market premium) will be added to the IPO GMP page as it will start).
